Public-registry trials using ANXV that Eichor's radar has found — 1 trial. All data below is from public sources; Eichor is not affiliated with any sponsor.
| Trial | Sponsor | Condition | Phase | Sites |
| Safety and Proof of Concept Study of ANXV (Annexin A5) in Patients With Retinal Vein Occlusion | Annexin Pharmaceuticals AB | Retinal Vein Occlusion | PHASE2 | 7 |
Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
